NCT04994821View on ClinicalTrials.gov

TDCS to Reduce Craving in Cocaine Addiction- Phase 2 Study

PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

September 28, 2020

Primary Completion Date

March 31, 2022

Study Completion Date

September 30, 2022

Conditions
Cocaine Use DisorderCocaine Dependence
Interventions
DEVICE

transcranial direct current stimulator (tDCS)

"Patients will have two electrodes applied (one anode, one cathode) administering active (real) or sham (placebo, not real) tDCS stimulation.~Stimulation will last 20 minutes per day, three days per week, for 5 weeks"

BEHAVIORAL

Cognitive Reappraisal

Emotion regulation therapy

Trial Locations (1)

10029

Icahn School of Medicine at Mount Sinai, New York

Sponsors

Lead Sponsor

Soterix Medical
All Listed Sponsors
collaborator

Icahn School of Medicine at Mount Sinai

OTHER

lead

Soterix Medical

INDUSTRY